Quantcast

Latest AbioMed Stories

2008-10-01 15:00:50

Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Artificial Organs Market http://www.reportlinker.com/p092544/World-Artificial-Organs-Market.html This report analyzes the worldwide markets for Artificial Organs in US$ Million. The major product segments analyzed are Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. Annual forecasts are provided for...

2008-09-16 15:00:38

Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City, New York. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum...

2008-09-02 09:00:43

Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008 at 9:45 a.m. ET. The conference will be held at the Grand Hyatt in New York City, New York. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the...

2008-08-22 12:00:52

Abiomed, Inc. (NASDAQ: ABMD) today announced the completion of the public offering of 2,419,932 shares of its common stock at $17.3788 per share. The net proceeds to Abiomed from the offering were approximately $41.7 million, after deducting the underwriting discount and estimated offering expenses. Morgan Stanley & Co. Incorporated was the sole underwriter for the offering. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the...

2008-08-07 09:01:05

Abiomed, Inc. (NASDAQ: ABMD) today announced first quarter of fiscal 2009 revenue of $16.4 million, up 16% compared to revenue of $14.1 million for the same period of fiscal 2008. Recent financial and operating highlights include: -- On June 2, 2008, Abiomed announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Impella(R) 2.5 Cardiac Assist Device. Through August 6, 2008, 56 of the approximately 1,700 U.S. hospitals with catheterization labs...

2008-07-31 12:01:06

Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, August 7, 2008, the Company will release first fiscal quarter 2009 results. The Company will host a conference call to discuss the results on Thursday, August 7, 2008, at 8:00 a.m. ET. Michael R. Minogue, Chairman, Chief Executive Officer and President, and Daniel J. Sutherby, Chief Financial Officer, will host the conference call. To listen to the call live, please tune into the webcast via http://investor.abiomed.com or...

2007-10-25 15:00:48

Abiomed, Inc. (NASDAQ: ABMD) formally announced the results of its Impella® 2.5 PROTECT I safety trial for the first time at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium and main sessions. PROTECT I is the first prospective multi-center, FDA-approved trial for prophylactic, or preventative, use of a device during high-risk percutaneous coronary intervention (PCI) procedures. The 20 patient...

2006-09-05 16:49:28

By Lisa Richwine WASHINGTON (Reuters) - Seriously ill heart failure patients expected to live only a month and ineligible for transplant can get an implant of a permanent artificial heart, U.S. health officials ruled on Tuesday. The grapefruit-sized, titanium-and-plastic device -- Abiomed Inc.'s AbioCor artificial heart -- may give patients only a few extra months and costs about $250,000. The 14 men who received the two-pound artificial heart in a study lived less than five months...


Latest AbioMed Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related